Search Within

Human Oncology and Pathogenesis Program

Formats
  1. Journal Article (3014)
  2. Meeting Abstract (2565)
  3. Review (137)
  4. Editorial (107)
  5. Book Section (54)
  6. Research Letter (42)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (16)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. GSK Faculty (5767)
  2. Department of Medicine (4318)
  3. Department of Pathology and Laboratory Medicine (3070)
  4. Tow Center for Developmental Oncology (TCDO) (2638)
  5. Solid Tumor Oncology Division (2633)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (2582)

More Groups

People
  1. Marc Ladanyi (1332)
  2. Ross Levine (785)
  3. David Solit (781)
  4. Michael Berger (769)
  5. Nikolaus Schultz (491)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (169)
  2. 2024 (381)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (649)
  2. Blood (517)
  3. Cancer Research (413)
  4. Modern Pathology (300)
  5. Clinical Cancer Research (269)
  6. Laboratory Investigation (265)

More Publications

Publishers
  1. American Association for Cancer Research (876)
  2. Nature Publishing Group (767)
  3. American Society of Clinical Oncology (717)
  4. American Society of Hematology (564)
  5. Elsevier Inc. (420)
  6. Nature Research (313)

More Publishers

Results (5985)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma
    Journal Article

    Venstrom, J. M.; Zheng, J.; Noor, N.; Danis, K. E.; Yeh, A. W.; Cheung, I. Y.; Dupont, B.; O'Reilly, R. J.; Cheung, N. K. V.; Hsu, K. C.
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save
  • The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers
    Journal Article

    Veeriah, S.; Brennan, C.; Meng, S.; Singh, B.; Fagin, J. A.; Solit, D. B.; Paty, P. B.; Rohle, D.; Vivanco, I.; Chmielecki, J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2009)

    Fulltext@MSK | Save
  • Can risk-adapted treatment recommendations replace the 'one size fits all' approach for early-stage thyroid cancer patients? - The Mazzaferri article reviewed [What is the optimal initial treatment of low-risk papillary thyroid cancer (and why is it controversial)]?
    Journal Article

    Tuttle, R. M.; Fagin, J. A.
    Oncology (Norwalk) (2009)

    Fulltext@MSK | Save
  • Mutation in TET2 in myeloid cancers
    Journal Article

    Tefferi, A.; Lim, K. H.; Levine, R.
    New England Journal of Medicine (2009)

    Fulltext@MSK | Save
  • TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis
    Journal Article

    Tefferi, A.; Pardanani, A.; Lim, K. H.; Abdel-Wahab, O.; Lasho, T. L.; Patel, J.; Gangat, N.; Finke, C. M.; Schwager, S.; Mullally, A.; more...
    Leukemia (2009)

    Fulltext@MSK | Save
  • Oncogenic Signals as Treatment Targets in Classic Myeloproliferative Neoplasms
    Journal Article

    Tefferi, A.; Levine, R. L.; Kantarjian, H.
    Biology of Blood and Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • Frequent TET2 mutations in systemic mastocytosis: Clinical, KITD816V and FIP1L1-PDGFRA correlates
    Journal Article

    Tefferi, A.; Levine, R. L.; Lim, K. H.; Abdel-Wahab, O.; Lasho, T. L.; Patel, J.; Finke, C. M.; Mullally, A.; Li, C. Y.; Pardanani, A.; more...
    Leukemia (2009)

    Fulltext@MSK | Save
  • Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
    Journal Article

    Tefferi, A.; Lim, K. H.; Abdel-Wahab, O.; Lasho, T. L.; Patel, J.; Patnaik, M. M.; Hanson, C. A.; Pardanani, A.; Gilliland, D. G.; Levine, R. L.
    Leukemia (2009)

    Fulltext@MSK | Save
  • The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation
    Journal Article

    Taulli, R.; Bersani, F.; Foglizzo, V.; Linari, A.; Vigna, E.; Ladanyi, M.; Tuschl, T.; Ponzetto, C.
    Journal of Clinical Investigation (2009)

    Fulltext@MSK | Save
  • Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis
    Journal Article

    Shen, R.; Olshen, A. B.; Ladanyi, M.
    Bioinformatics (2009)

    Fulltext@MSK | Save